Immune Profiling of Stage III Non-small Cell Lung Cancer Patients Treated With Concurrent Chemoradiation and Adjuvant Durvalumab: A Prospective Observational Phase II Trial
Clinical trial NCT04432142 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04432142
- Sponsor
- Maastricht Radiation Oncology
- Status
- ACTIVE_NOT_RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2021-04-01
- Primary completion
- 2024-07-01
- Enrollment
- 45
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.